ATE185376T1 - Verfahren zur messung von gewebeplasminogenaktivator, antithrombin-iii und lösliches fibrin - Google Patents
Verfahren zur messung von gewebeplasminogenaktivator, antithrombin-iii und lösliches fibrinInfo
- Publication number
- ATE185376T1 ATE185376T1 AT93113125T AT93113125T ATE185376T1 AT E185376 T1 ATE185376 T1 AT E185376T1 AT 93113125 T AT93113125 T AT 93113125T AT 93113125 T AT93113125 T AT 93113125T AT E185376 T1 ATE185376 T1 AT E185376T1
- Authority
- AT
- Austria
- Prior art keywords
- plasminogen activator
- tissue plasminogen
- antithrombin
- iii
- measuring tissue
- Prior art date
Links
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title abstract 3
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title abstract 3
- 229960000187 tissue plasminogen activator Drugs 0.000 title abstract 2
- 102000004411 Antithrombin III Human genes 0.000 title 1
- 108090000935 Antithrombin III Proteins 0.000 title 1
- 102000009123 Fibrin Human genes 0.000 title 1
- 108010073385 Fibrin Proteins 0.000 title 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 title 1
- 229960005348 antithrombin iii Drugs 0.000 title 1
- 229950003499 fibrin Drugs 0.000 title 1
- 102000001938 Plasminogen Activators Human genes 0.000 abstract 1
- 108010001014 Plasminogen Activators Proteins 0.000 abstract 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 abstract 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940127126 plasminogen activator Drugs 0.000 abstract 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8132—Plasminogen activator inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9726—Tissue plasminogen activator
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7006887A | 1987-07-06 | 1987-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE185376T1 true ATE185376T1 (de) | 1999-10-15 |
Family
ID=22092923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93113125T ATE185376T1 (de) | 1987-07-06 | 1988-07-05 | Verfahren zur messung von gewebeplasminogenaktivator, antithrombin-iii und lösliches fibrin |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP0324027A4 (de) |
| JP (1) | JP2710376B2 (de) |
| AT (1) | ATE185376T1 (de) |
| AU (1) | AU2314688A (de) |
| CA (1) | CA1324748C (de) |
| DE (1) | DE3856367T2 (de) |
| WO (1) | WO1989000005A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352583A (en) * | 1989-10-02 | 1994-10-04 | Teijin Limited | Human tissue plasminogen activator-human plasminogen activator inhibitor complex immunoassay and kit therefor |
| AU644205B2 (en) * | 1990-08-23 | 1993-12-02 | New York Blood Center, Inc., The | Assays using a soluble fibrin-like monomer |
| SE9201615L (sv) * | 1992-05-21 | 1993-11-22 | Chromogenix Ab | Bioimmunologisk metod för bestämning av tPa och PAI-1 |
| AU7384494A (en) * | 1993-06-28 | 1995-01-24 | Akzo Nobel N.V. | Quantification of active plasminogen-activator-inhibitor-type-1 |
| US5843608A (en) * | 1995-06-08 | 1998-12-01 | Coulter International Corp. | Reagent and method for differential determination of leukocytes in blood |
| US5762255A (en) * | 1996-02-20 | 1998-06-09 | Richard-Allan Medical Industries, Inc. | Surgical instrument with improvement safety lockout mechanisms |
| WO1998043686A1 (en) | 1997-04-03 | 1998-10-08 | California Institute Of Technology | Enzyme-mediated modification of fibrin for tissue engineering |
| FR2813395B1 (fr) | 2000-08-28 | 2003-01-24 | Stago Diagnostica | Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques |
| US7473548B2 (en) | 2003-04-25 | 2009-01-06 | Medtronic, Inc. | Optical detector for enzyme activation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8201987A (nl) * | 1982-05-13 | 1983-12-01 | Tno | Werkwijze voor het bepalen van de activiteit van plasminogeenactivator van het weefseltype, alsmede voor gebruik bij deze werkwijze geschikte combinatie van het "kit"-type. |
| DE3430906A1 (de) * | 1984-08-22 | 1986-02-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung von fibrinmonomer in plasma |
| SE447579B (sv) * | 1985-04-01 | 1986-11-24 | Biopool Ab | Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar |
-
1988
- 1988-07-05 CA CA000571186A patent/CA1324748C/en not_active Expired - Fee Related
- 1988-07-05 WO PCT/US1988/002277 patent/WO1989000005A1/en not_active Ceased
- 1988-07-05 AU AU23146/88A patent/AU2314688A/en not_active Abandoned
- 1988-07-05 DE DE3856367T patent/DE3856367T2/de not_active Expired - Fee Related
- 1988-07-05 JP JP63506985A patent/JP2710376B2/ja not_active Expired - Fee Related
- 1988-07-05 EP EP19880908071 patent/EP0324027A4/en not_active Withdrawn
- 1988-07-05 AT AT93113125T patent/ATE185376T1/de not_active IP Right Cessation
- 1988-07-05 EP EP93113125A patent/EP0576038B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0324027A1 (de) | 1989-07-19 |
| JP2710376B2 (ja) | 1998-02-10 |
| EP0576038B1 (de) | 1999-10-06 |
| CA1324748C (en) | 1993-11-30 |
| EP0324027A4 (en) | 1990-10-10 |
| WO1989000005A1 (en) | 1989-01-12 |
| DE3856367D1 (de) | 1999-11-11 |
| DE3856367T2 (de) | 2000-05-11 |
| AU2314688A (en) | 1989-01-30 |
| EP0576038A2 (de) | 1993-12-29 |
| EP0576038A3 (en) | 1994-06-08 |
| JPH02500805A (ja) | 1990-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3874798D1 (de) | Therapeutisches proteinagens in form von aerosol. | |
| AT349154B (de) | Verfahren zur bestimmung von proteolytischen enzymen der gruppe e.c. 3.4.4. | |
| DE69018910D1 (de) | Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren. | |
| NO851225L (no) | Sammensetning og forsoeksinnretning til bestemmelse av tilstedevaerelsen av leukocytter, esterase og protease i en proeve | |
| DE3680271D1 (de) | Thrombolytische zusammensetzung und verfahren zu deren herstellung. | |
| DE3788762D1 (de) | Verfahren zur Bestimmung von physiologisch wirksamen Substanzen. | |
| ATE185376T1 (de) | Verfahren zur messung von gewebeplasminogenaktivator, antithrombin-iii und lösliches fibrin | |
| ES541871A0 (es) | Un procedimiento para la preparacion de nuevos derivados de pirrol. | |
| ATA375877A (de) | Verfahren zur quantitativen bestimmung von proteolytischen enzymen | |
| ATE17262T1 (de) | Verfahren zur quantitativen bestimmung von blutgerinnungsfaktor xii in humanplasma. | |
| ATE20780T1 (de) | Methode zur fruehbestimmung der schwangerschaft. | |
| DK226889A (da) | Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation | |
| ATE40718T1 (de) | Verfahren zur bestimmung von fibrinmonomer in plasma. | |
| DE69124030D1 (de) | Testverfahren, die ein lösliches fibrinähnliches Monomer nutzen | |
| DE3680507D1 (de) | Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie. | |
| ATE128239T1 (de) | Mittel zur verbesserung der wiederfindung von annexinen. | |
| DE3851304D1 (de) | Verfahren und Testzusammensetzung zur Bestimmung von Enzym-Aktivität. | |
| KR900700443A (ko) | 머캅토-아실아미노산 항고혈압제 | |
| ATE64470T1 (de) | Verfahren und zusammensetzungen zur bestimmung von heparin. | |
| ATA99992A (de) | Verfahren zur bestimmung von fibrinogen | |
| ATE138478T1 (de) | Kalibrator und verwendung davon in einer immuntest | |
| ATE115188T1 (de) | Antikörper gegen fibrin, immunogen zur herstellung desselben, verfahren zur bestimmung von fibrin und pharmazeutisches präparat auf basis der antikörper. | |
| ATE85365T1 (de) | Verfahren zur bestimmung von protein c-inhibitor. | |
| ATE29785T1 (de) | Verfahren zur feststellung der allergischen empfindlichkeit. | |
| JPS6488368A (en) | Method for measuring complex of urokinase and urokinase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |